Analysis of hepatitis b virus populations in an interferon-α-treated patient reveals predominant mutations in the c-gene and changing e- antigenicity

Virology

Volumn 244, Issue 1, 1998, Pages 146-160

  Günther, Stephan ^a   Paulij, Wilma ^c   Meisel, Helga ^b   Will, Hans ^a  

^a LEIBNIZ INSTITUTE FOR EXPERIMENTAL VIROLOGY   (Germany)

^b HUMBOLDT UNIVERSITY   (Germany)

^c NONE

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA INTERFERON; EPITOPE;

ANTIGEN RECOGNITION; ANTIGENICITY; ARTICLE; GENE MUTATION; GENE SEQUENCE; HEPATITIS B; HEPATITIS B VIRUS; NONHUMAN; PRIORITY JOURNAL; VIRUS REPLICATION;

DNA VIRUSES; HEPATITIS B VIRUS;

EID: 17544403729     PISSN: 00426822     EISSN: None     Source Type: Journal    
DOI: 10.1006/viro.1998.9079     Document Type: Article

References (57)

1. Arii M., Takada S., Koike K. Identification of three essential regions of hepatitis B virus X protein for trans-activation function. Oncogene. 7:1992;397-403.
2. Bertoletti A., Costanzo A., Chisari F. V., Levrero M., Artini M., Sette A., Penna A., Giuberti T., Fiaccadori F., Ferrari C. Cytotoxic T lymphocyte response to a wild type hepatitis B virus epitope in patients chronically infected by variant viruses carrying substitutions within the epitope. J. Exp. Med. 180:1994;933-943.
3. Brunetto M. R., Giarin M. M., Oliveri F., Chiaberge E., Baldi M., Alfarano A., Serra A., Saracco G., Verme G., Will H., Bonino F. Wild-type and e antigen-minus hepatitis B viruses and course of chronic hepatitis. Proc. Natl. Acad. Sci. USA. 88:1991;4186-4190.
4. Buckwold V. E., Xu Z. C., Chen M., Yen T., Ou J. H. Effects of a naturally occurring mutation in the hepatitis B virus basal core promoter on precore gene expression and viral replication. J. Virol. 70:1996;5845-5851.
5. Carman W. F., Boner W., Fattovich G., Colman K., Dornan E. S., Thursz M., Hadziyannis S. Hepatitis B virus core protein mutations are concentrated in B cell epitopes in progressive disease and in T helper cell epitopes during clinical remission. J. Infect. Dis. 175:1997;1093-1100.
6. Carrigan D. R., Kehl-Knox K. Identification of interferon-resistant subpopulations in several strains of measles virus: positive selection by growth of the virus in brain tissue. J. Virol. 64:1990;1606-1615.
7. Chisari F. V., Ferrari C. Hepatitis B virus immunopathogenesis. Annu. Rev. Immunol. 13:1995;29-60.
8. Cooke M. P., Heath A. W., Shokat K. M., Zeng Y., Finkelmann F. D., Linsley P. S., Howard M., Goodnow C. C. Immunoglobulin signal transduction guides the specifity of B cell-T cell interactions and is blocked in tolerant self-reactive B cells. J. Exp. Med. 179:1994;425-438.
9. Cullen B. R., Malim M. H. Secreted placental alkaline phosphatase as a eukaryotic reporter gene. Methods Enzymol. 216:1992;326-368.
10. Ehata T., Omata M., Yokosuka O., Hosoda K., Ohto M. Variations in codons 84-101 in the core nucleotide sequence correlate with hepatocellular injury in chronic hepatitis B virus infection. J. Clin. Invest. 89:1992;332-338.
11. Ferrari C., Penna A., Bertoletti A., Valli A., Antoni A. D., Giuberti T., Cavalli A., Petit M. A., Fiaccadori F. Cellular immune response to hepatitis B virus-encoded antigens in acute and chronic hepatitis B virus infection. J. Immunol. 145:1990;3442-3449.
12. Ferrari C., Bertoletti A., Penna A., Cavalli A., Valli A., Missale G., Pilli M., Fowler P., Giuberti T., Chisari F. V., Fiaccadori F. Identification of immunodominant T cell epitopes of the hepatitis B virus nucleocapsid antigen. J. Clin. Invest. 88:1991;214-222.
13. Galibert F., Mandart E., Fitoussi F., Tiollais P., Charnay P. Nucleotide sequence of the hepatitis B genome (subtype ayw) cloned inE. coli. Nature (London). 281:1979;646-650.
14. Guidotti L. G., Ishikawa T., Hobbs M. V., Matzke B., Schreiber R., Chisari F. V. Intracellular inactivation of the hepatitis B virus by cytotoxic T lymphocytes. Immunity. 4:1996;25-36.
15. Günther S., Meisel H., Reip A., Miska S., Krüger D. H., Will H. Frequent and rapid emergence of mutated pre-C sequences in HBV from e-antigen positive carriers who seroconvert to anti-HBe during interferon treatment. Virology. 187:1992;271-279.
16. Günther S., Li B. C., Miska S., Krüger D. H., Meisel H., Will H. A novel method for efficient amplification of whole hepatitis B virus genomes permits rapid functional analysis and reveals deletion mutants in immunosuppressed patients. J. Virol. 69:1995;5437-5444.
17. Günther S., Piwon N., Iwanska A., Schilling R., Meisel H., Will H. Type, prevalence, and significance of core promoter/enhancer II mutations in hepatitis B viruses from immunosuppressed patients with severe liver disease. J. Virol. 70:1996;8318-8331.
18. Günther S., Piwon N., Will H. Wild-type levels of pregenomic RNA and replication but reduced pre-C RNA and e-antigen synthesis of hepatitis B virus with C(1653)-T, A(1762)-T and G(1764)-A mutations in the core promoter. J. Gen. Virol. 79:1998;375-380.
19. Hasegawa K., Huang J., Rogers S. A., Blum H. E., Liang T. J. Enhanced replication of a hepatitis B virus mutant associated with an epidemic of fulminant hepatitis. J. Virol. 68:1994;1651-1659.
20. Hayashi Y., Koike K. Interferon inhibits hepatitis B virus replication in a stable expression system of transfected viral DNA. J. Virol. 63:1989;2936-2940.
21. He X.-S., Chen H.-S., Chu K., Rivkina M., Robinson W. S. Costimulatory protein B7-1 enhances the cytotoxic T cell response and antibody response to hepatitis B surface antigen. Proc. Natl. Acad. Sci. USA. 93:1996;7274-7278.
22. Hoofnagle J. H., Dusheiko G. M., Seeff L. B., Jones E. A., Waggoner J. G., Bales Z. B. Seroconversion from hepatitis B e antigen to antibody in chronic type B hepatitis. Ann. Intern. Med. 94:1981;744-748.
23. Imai M., Nomura M., Gotanda T., Sano T., Tachibana K., Miyamoto H., Takahashi K., Toyama S., Miyakawa Y., Mayumi M. Demonstration of two distinct antigenic determinants on the hepatitis B e antigen by monoclonal antibodies. J. Immunol. 128:1982;69-72.
24. Jilbert A. R., Wu T. T., England J. M., Hall P. M., Carp N. Z., O'Connell A. P., Mason W. S. Rapid resolution of duck hepatitis B virus infections occurs after massive hepatocellular involvement. J. Virol. 66:1992;1377-1388.
25. Jung M. C., Spengler U., Schraut W., Hoffmann R., Zachoval R., Eisenburg J., Eichenlaub D., Riethmüller G., Paumgartner G., Ziegler-Heitbrock H. W. L., Will H., Pape G. R. Hepatitis B virus antigen-specific T-cell activation in patients with acute and chronic hepatitis B. J. Hepatol. 13:1991;310-317.
26. Kajino K., Jilbert A. R., Saputelli J., Aldrich C. E., Cullen J., Mason W. S. Woodchuck hepatitis virus infections: Very rapid recovery after a prolonged viremia and infection of virtually every hepatocyte. J. Virol. 68:1994;5792-5803.
27. Lenschow D. J., Sperling A. I., Cooke M. P., Freeman G., Rhee L., Decker D. C., Gray G., Nadler L. M., Goodnow C. C., Bluestone J. A. Differential up-regulation of the B7-1 and B7-2 costimulatory molecules after Ig receptor engagement by antigen. J. Immunol. 153:1994;1990-1997.
28. Linsley P. S., Brady W., Grosmaire L., Aruffo A., Damle N. K., Ledbetter J. A. Binding of the B cell activation antigen B7 to CD28 costimulates T cell proliferation and interleukin 2 mRNA accumulation. J. Exp. Med. 173:1991;721-730.
29. López-Cabrera M., Letovsky J., Hu K.-Q., Siddiqui A. Multiple liver-specific factors bind to the hepatitis B virus core/pregenomic promoter: Trans-activation and repression by CCAAT/enhancer binding protein. Proc. Natl. Acad. Sci. USA. 87:1990;5069-5073.
30. Maruyama T., McLachlan A., Iino S., Koike K., Kurokawa K., Milich D. R. The serology of chronic hepatitis B infection revisited. J. Clin. Invest. 91:1993;2586-2595.
31. Michalak T. I., Lin B., Churchill N. D., Dzwonkowski P., Desousa J. R. Hepadna virus nucleocapsid and surface antigens and the antigen-specific antibodies associated with hepatocyte plasma membranes in experimental woodchuck acute hepatitis. Lab. Invest. 62:1990;680-689.
32. Michalak T. I., Lin B. Molecular species of hepadnavirus core and envelope polypeptides in hepatocyte plasma membrane of woodchucks with acute and chronic viral hepatitis. Hepatology. 20:1994;275-286.
33. Michalak T. I., Lau J. Y., McFarlane B. M., Alexander G. J., Eddleston A. L., Williams R. Antibody-directed complement-mediated cytotoxicity to hepatocytes from patients with chronic hepatitis B. Clin. Exp. Immunol. 100:1995;227-232.
34. Miles S. A., Balden E., Magpantay L., Wei L., Leiblein A., Hofheinz D., Toedter G., Stiehm E. R., Bryson Y. Rapid serologic testing with immune-complex-dissociated HIV p24 antigen for early detection of HIV infection in neonates. N. Engl. J. Med. 328:1993;297-302.
35. Milich D. R., Jones J. E., Hughes J. L., Price J., Raney A. K., McLachlan A. Is a function of the secreted hepatitis B e antigen to induce immunologic tolerancein utero. Proc. Natl. Acad. Sci. USA. 87:1990;6599-6603.
36. Miska S. Vorkommen, Selektion und Bedeutung von Hepatitis-B-Virus C-Gen Varianten. 1996;University of Hamburg.
37. Möller B., Hopf U., Stemerowicz R., Henze G., Gelderblom H. HBcAg expressed on the surface of circulating Dane particles in patients with hepatitis B virus infection without evidence of anti-HBc formation. Hepatology. 10:1989;179-185.
38. Moskophidis D., Battegay M., Bruendler M.-A., Laine E., Gresser I., Zinkernagel R. M. Resistance of lymphocytic choriomeningitis virus to alpha/beta interferon and to gamma interferon. J. Virol. 68:1994;1951-1955.
39. Okamoto H., Yotsumoto S., Akahane Y., Yamanaka T., Miyazaki Y., Sugai Y., Tsuda F., Tanaka T., Miyakawa Y., Mayumi M. Hepatitis B viruses with precore region defects prevail in persistently infected hosts along with seroconversion to the antibody against e antigen. J. Virol. 64:1990;1298-1303.
40. Okamoto H., Tsuda F., Akahane Y., Sugai Y., Yoshiba M., Moriyama K., Tanaka T., Miyakawa Y., Mayumi M. Hepatitis B virus with mutations in the core promoter for an e antigen-negative phenotype in carriers with antibody to e antigen. J. Virol. 68:1994;8102-8110.
41. Penna A., Chisari F. V., Bertoletti A., Missale G., Fowler P., Giuberti T., Fiaccadori F., Ferrari C. Cytotoxic T lymphocytes recognize an HLA-A2-restricted epitope within the hepatitis B virus nucleocapsid antigen. J. Exp. Med. 174:1991;1565-1570.
42. Pirovino M., Aguet M., Huber M., Altdorfer J., Schmid M. Absence of detectable serum interferon in acute and chronic viral hepatitis. Hepatology. 6:1986;645-647.
43. Rammensee H.-G., Friede T., Stevanovic S. MHC ligands and peptide motifs: First listing. Immunogenetics. 41:1995;178-228.
44. Raney A. K., Johnson J. L., Palmer C. N. A., McLachlan A. Members of the nuclear receptor superfamily regulate transcription from the hepatitis B virus nucleocapsid promoter. J. Virol. 71:1997;1058-1071.
45. Rehermann B., Pasquinelli C., Mosier S. M., Chisari F. V. Hepatitis B virus (HBV) sequence variation of cytotoxic T lymphocyte epitopes is not common in patients with chronic HBV infection. J. Clin. Invest. 96:1995;1527-1534.
46. Salfeld J., Pfaff E., Noah M., Schaller H. Antigenic determinants and functional domains in core antigen and e antigen from hepatitis B virus. J. Virol. 63:1989;798-808.
47. Schlicht H. J. Biosynthesis of the secretory core protein of duck hepatitis B virus: Intracellular transport, proteolytic processing, and membrane expression of the precore protein. J. Virol. 65:1991;3489-3495.
48. Schlicht H. J., Schaller H. The secretory core protein of human hepatitis B virus is expressed on the cell surface. J. Virol. 63:1989;5399-5404.
49. Schlicht H. J., Brunn A., Theilmann L. Antibodies in anti-HBe-positive patient sera bind to HBe protein expressed on the cell surface of human hepatoma cells: Implications for virus clearance. Hepatology. 13:1991;57-61.
50. Stephan W., Prince M. A., Brotman B. Modulation of hepatitis B infection by intravenous application of an immunoglobulin preparation that contains antibodies to hepatitis B e and core antigens but not to hepatitis B surface antigen. J. Virol. 51:1984;420-424.
51. Su Y.-H., Oakes J. E., Lausch R. N. Ocular avirulence of a herpes simplex virus type I strain is associated with heightened sensitivity to alpha/beta interferon. J. Virol. 64:1990;2187-2192.
52. Tsai S. L., Chen P. J., Lai M. Y., Yang P. M., Sung J. L., Huang J. H., Hwang L. H., Chang T. H., Chen D. S. Acute exacerbations of chronic type B hepatitis are accompanied by increased T cell responses to hepatitis B core and e antigens. Implications for hepatitis B e antigen seroconversion. J. Clin. Invest. 89:1992;87-96.
53. Tsui L. V., Guidotti L. G., Ishikawa T., Chisari F. V. Posttranscriptional clearance of hepatitis B virus RNA by cytotoxic T lymphocyte-activated hepatocytes. Proc. Natl. Acad. Sci. USA. 92:1995;12398-12402.
54. Whitten T. M., Quets A. T., Schloemer R. H. Identification of the hepatitis B virus factor that inhibits expression of the beta interferon gene. J. Virol. 65:1991;4699-4704.
55. Yuan T. T. T., Faruqi A., Shih J. W., Shih C. The mechanism of natural occurrence of two closely linked HBV precore predominant mutations. Virology. 211:1995;144-156.
56. Yuh C.-H., Ting L.-P. C/EBP-like proteins binding to the functional box-alpha and box-beta of the second enhancer of hepatitis B virus. Mol. Cell. Biol. 11:1991;5044-5052.
57. Yuh C.-H., Chang Y.-L., Ting L.-P. Transcriptional regulation of precore and pregenomic RNAs of hepatitis B virus. J. Virol. 66:1992;4073-4084.